↓ Skip to main content

L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease

Overview of attention for article published in Lipids in Health and Disease, April 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
2 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease
Published in
Lipids in Health and Disease, April 2014
DOI 10.1186/1476-511x-13-69
Pubmed ID
Authors

Irina Voloshin, Michal Hahn-Obercyger, Sarit Anavi, Oren Tirosh

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a continuum of diseases that include simple steatosis and non-alcoholic steatohepatitis (NASH) ultimately leading to cirrhosis, hepatocellular carcinoma and end stage liver failure. Currently there is no approved treatment for NASH. It is known that bile acids not only have physiological roles in lipid digestion but also have strong hormonal properties. We have synthesized a novel chenodeoxycholyl-arginine ethyl ester conjugate (CDCArg) for the treatment of NAFLD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 20%
Student > Bachelor 4 13%
Other 3 10%
Student > Ph. D. Student 3 10%
Researcher 3 10%
Other 3 10%
Unknown 8 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 23%
Medicine and Dentistry 6 20%
Agricultural and Biological Sciences 6 20%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Economics, Econometrics and Finance 1 3%
Other 1 3%
Unknown 8 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2021.
All research outputs
#7,098,079
of 24,677,985 outputs
Outputs from Lipids in Health and Disease
#446
of 1,559 outputs
Outputs of similar age
#63,775
of 232,116 outputs
Outputs of similar age from Lipids in Health and Disease
#5
of 20 outputs
Altmetric has tracked 24,677,985 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,559 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 232,116 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.